A 9-yr evaluation of carrier erythrocyte encapsulated adenosine deaminase (ADA) therapy in a patient with adult-type ADA deficiency. [electronic resource]
Producer: 20071213Description: 338-48 p. digitalISSN:- 0902-4441
- Adenosine Deaminase -- administration & dosage
- Adenosylhomocysteinase -- immunology
- Adult
- Antigens, CD20 -- blood
- Autoantibodies -- blood
- Deoxyadenine Nucleotides -- immunology
- Enzymes, Immobilized -- administration & dosage
- Erythrocytes -- enzymology
- Female
- Forced Expiratory Flow Rates -- drug effects
- Humans
- Immunoglobulin G -- blood
- Lung Diseases -- enzymology
- Lymphocyte Count
- Polyethylene Glycols -- administration & dosage
- Severe Combined Immunodeficiency -- drug therapy
- Time Factors
No physical items for this record
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.